LeonaBio, Inc.
LONA · XNASCIK 1620463fmd_1ZJCMPTG96AHJ8PYT11912V95AManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Jun 30, 2026, 28 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Research and development | 4 | 13 | 43 | 61 | 94 | 71 | 18 |
| Operating income | (5) | (20) | (64) | (104) | (125) | (101) | (102) |
| Interest expense | 0 | 0 | 0 | – | – | – | – |
| Interest and investment income | 0 | 0 | 0 | – | – | – | – |
| Other non-operating income (expense) | (0) | (1) | 0 | 3 | 8 | 4 | 1 |
| Income before taxes | (5) | (20) | (55) | (96) | (118) | (97) | (106) |
| Income tax expense | – | – | – | – | – | – | 0 |
| Net income from continuing operations | – | – | – | – | – | – | (106) |
| Net income | (5) | (20) | (55) | (96) | (118) | (97) | (106) |